Patient


  • Methadone at home
    Image attribution tooltip
    Stock via Getty Images

    Methadone at home? Emerging tech provides new tool in the fight against opioid addiction

    Sonara Health’s inexpensive, specially engineered label and web app allow for at-home, digitally supervised dosing of high-cost or high-risks drugs.

    By Alexandra Pecci • Sept. 15, 2022
  • Senior mature business woman holding paper
    Image attribution tooltip

    Ground+Picture/shutterstock.com/

    Sponsored by GoodRx

    Medication affordability’s impact on adherence and outcomes

    Improved patient affordability is an important lever that can increase adherence, which in turn can improve health outcomes.

    Sept. 12, 2022
  • A 3D illustration of sickled cells in blood
    Image attribution tooltip
    Artur Plawgo via Getty Images

    Pharma’s renewed sickle cell investment lifts a once-shirked disease

    Pfizer's $5.4 billion deal to acquire Global Blood Therapeutics invigorated the fast-growing market, and patients are fit to be the benefactors.

    By Kelly Bilodeau • Sept. 1, 2022
  • Abstract digital design with hands holding a single pill
    Image attribution tooltip

    adobe.stock.com/Art N More

    Sponsored by EVERSANA

    Flipping the script to disrupt, redefine and accelerate the patient care journey

    A new, digitally innovative care model empowers patients and expedites their access to treatment.

    Aug. 22, 2022
  • President Biden signs the Inflation Reduction Act surrounded by members of congress and backed by American flags in the White House.
    Image attribution tooltip
    Drew Angerer via Getty Images

    3 ways pharma can prep for Biden’s sweeping drug pricing policies

    Now that Medicare will be able to negotiate drug prices under the Inflation Reduction Act, the industry can expect to see some changes. Here are some tips on how to navigate the changing tide.

    By Aug. 18, 2022
  • George Magrath wears blue scrubs and sits over a patient.
    Image attribution tooltip

    Permission granted by George Magrath. 

    The CEO in the ophthalmologist’s coat

    In balancing two roles — Lexitas CEO and practicing physician — George Magrath brings a patient-first perspective to developing and advancing eye treatments.

    By Alexandra Pecci • Aug. 16, 2022
  • Nasal spray
    Image attribution tooltip
    Evgenyi_Eg via Getty Images

    Right under our noses: Could COVID-19 vaccines be better as nasal spray?

    Nasal vaccines under development by Codagenix, Xanadu Bio and others have the potential to finally help reduce virus transmission and breakthrough infections.

    By Kelly Bilodeau • Aug. 16, 2022
  • ARLINGTON, VA - JUNE 05: Recently laid off worker Lyn Talent receives a free Botox injection during an event called the "The Botox Bailout."
    Image attribution tooltip
    Win McNamee/Staff via Getty Images

    Despite AbbVie’s Botox prowess, underdog Galderma has leveraged soft skills to succeed in aesthetics

    Galderma may not have the biggest name in aesthetics, but as the sector grows past pandemic lows, the company is relying on its people to build a loyal customer base.

    By Aug. 11, 2022
  • cell therapy infusion
    Image attribution tooltip
    Stock via Getty Images

    4 ways to nail the launch of your cell therapy

    A consultant’s view on how pharma companies should approach patient experience challenges when rolling out an autologous cell therapy.

    By Aug. 10, 2022
  • monkeypox vax
    Image attribution tooltip
    Mario Tama via Getty Images

    The ‘alarming’ spread of Monkeypox — by the numbers

    With vaccine and treatment supplies constrained, the virus is becoming ‘less predictable.’

    By Aug. 8, 2022
  • Pills, blister packs, medical bottles, laptop
    Image attribution tooltip
    MJ_Prototype via Getty Images

    Generic subscription services like Mark Cuban’s promise cheaper drugs — but will it work?

    Companies like Cost Plus Drugs and DiRx can bring generics directly to consumers at a fraction of the price, but whether it’s enough to fix the inflated U.S. healthcare system is yet to be seen.

    By Aug. 4, 2022
  • long covid
    Image attribution tooltip
    Lisa Maree Williams via Getty Images
    Q&A

    Lupus discovery lends clues to the fight against long COVID

    So far, pharma has yet to provide an answer for long COVID. But award-winning lupus research by Yale professor Akiko Iwasaki could help lead the way.

    By Kelly Bilodeau • July 27, 2022
  • A view of the Capitol Dome from below with an American flag waving in the wind on the left side and blue skies in the background.
    Image attribution tooltip
    iStock via Getty Images

    Democrats think they've found a balance between drug innovation and pricing negotiation

    A look at Congress’ push to pass drug pricing reform and why the latest attempt could actually succeed.

    By July 26, 2022
  • newborn screening
    Image attribution tooltip
    Stock via Getty Images

    The earlier the better: New consortium leverages infant screening to accelerate treatment

    Inozyme Pharma has joined a genomic sequencing program developing a novel rapid test for 388 genetic diseases.

    By Kim Ribbink • July 25, 2022
  • A man walks out of the Pfizer world headquarters building.
    Image attribution tooltip
    Chris Hondros / Staff via Getty Images
    Q&A

    Behind Pfizer's new quest to target a 'transformation' in pharma

    A combined venture with Roivant — called Priovant Therapeutics — is looking to be a forerunner in the burgeoning autoimmune disease market.

    By Kelly Bilodeau • July 25, 2022
  • A red Moderna sign hangs on the front of a beige building.
    Image attribution tooltip
    Maddie Meyer / Staff via Getty Images

    Moderna's next vax target? A little-known cause of birth defects

    How the mRNA-based biotech is developing the first-ever prophylactic for a devastating virus.

    By July 21, 2022
  • John LaMattina
    Image attribution tooltip

    Permission granted by John LaMattina

    Pfizer's former R&D head takes on drug pricing misconceptions in new book

    John LaMattina has something to say about the industry — and he hopes patients are listening.

    By July 19, 2022
  • science discovery and technological innovation
    Image attribution tooltip

    NanoStockk/istockphoto.com

    Sponsored by OPEN Health

    How digital health is changing the relationship between patients and health providers

    The pandemic has forced the pharmaceutical industry to look at digital in a new way - and it’s driving better health outcomes

    July 18, 2022
  • Son holding father's hand at the hospital
    Image attribution tooltip
    FG Trade via Getty Images
    Profile

    The power of the underdog: A rare disease nonprofit working to help patients win against the odds

    Elizabeth Izard Apelles is finding innovative ways to champion rare disease patients through an emerging platform from Honeycomb Health.

    By Alexandra Pecci • July 13, 2022
  • Geometric illustration of multi-colored human figures
    Image attribution tooltip
    iStock via Getty Images

    Pharma companies take a fresh approach to inclusion in new DTC ads

    AstraZeneca and Amgen are emphasizing diversity and authenticity in campaigns for lupus and severe asthma therapies.

    By July 5, 2022
  • Oral contraceptive pill on pharmacy counter with colorful pills strips background.
    Image attribution tooltip
    iStock via Getty Images

    With abortion access restricted across the U.S., a new diagnostic aims to eliminate birth control's pain points

    The hormonal and genetic test developed by Adyn is designed to predict and prevent adverse birth control side effects.

    By June 28, 2022
  • Image attribution tooltip
    Stock via Getty Images

    The oncology market is surging despite a decline in routine screenings

    A new report from IQVIA reveals the current challenges — and promise — in cancer drug R&D.

    By Kelly Bilodeau • June 28, 2022
  • Image attribution tooltip

    Permission granted by Dan Vahdat.

    Q&A

    'Nobel Prize of pharma' helps put Huma's digital health platform on the global map

    The company’s CEO explains how its Prix Galien award-winning app bridges patient care, treatment support and clinical research.

    By Kim Ribbink • June 23, 2022
  • Image attribution tooltip
    Karissa Waddick/PharmaVoice

    #DIA2022: Building 'guardrails' in the FDA's accelerated approval program

    Regulatory experts weigh in on ways to enhance the controversial drug approval approach.

    By June 21, 2022
  • A person in a white doctors coat and stethoscope holds up a magnifying glass.
    Image attribution tooltip
    Valiantsin Suprunovich via Getty Images

    The public health sleuth

    In her decades-long career, Mary Pittman, CEO of the Public Health Institute, has seen — and helped solve — one public health mystery after another.

    By Alexandra Pecci • June 21, 2022